Asialo von Willebrand Factor Enhances Platelet Adhesion to Vessel Subendothelium

Summary

Native von Willebrand factor (N-vWF) binds to platelets activated by thrombin, ADP or ristocetin. Asialo vWF (As-vWF) induces platelet aggregation in absence of platelet activators. N-vWF mediates platelet adhesion to vessel subendothelium at high shear rates. We have investigated the role of As-vWF in supporting platelet deposition to rabbit vessel subendothelium at a shear rate of 2,000 sec^-1, using the Baumgartner perfusion system. We have studied the effects of the addition of As-vWF (from 2 to 12 μg/ml) to perfusates consisting of washed red blood cells, 4% human albumin and washed platelets. Our results show a significant increase in platelet deposition on subendothelium (p <0.01) in perfusions to which As-vWF had been added. Blockage of the platelet glycoproteins Ib and IIb/IIIa (GPIb and GPIIb/IIIa) by specific monoclonal antibodies (LJIb1 and LJCP8, respectively) resulted in a decrease of platelet deposition in both types of perfusates prepared with N-vWF and As-vWF. Our results indicate that As-vWF enhances platelet deposition to vessel subendothelium under flow conditions. Furthermore, they suggest that this effect is mediated by the binding of As-vWF to platelet membrane receptors, which in turn, promote platelet spreading and adhesion to the subendothelium.

Key words

Asialo von Willebrand factor - Platelet adhesion - Flow system

• References

• 1 Switzer ME, McKee PA. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure. J Clin Invest 1976; 57: 925-937
• 2 Zimmermann TS, Ruggeri ZM. Von Willebrand disease. Prog Haemostas Thromb 1982; 6: 203-236
• 3 Zucker MB, Kim SJ, McPherson J, Grant RA. Binding of factor VIII to platelets in the presence of ristocetin. Br J Haematol 1977; 35: 535-549
• 4 Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR. Platelets have more than one binding site for von Willebrand factor. J Clin Invest 1983; 72: 1-12
• 5 Santoro SA. Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen. Biochem Biophys Acta 1983; 756: 123-126
• 6 Sixma JJ, Sakariassen KS, Stel HV, Houdijk WP M, In der Maur DW, Hamer RJ, De Groot Ph G, Van Mourik JA. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen. J Clin Invest 1984; 74: 736-744
• 7 Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendotheliums is mediated by factor VIII - von Willebrand factor bound to the subendothelium. Nature 1979; 279: 636-638
• 8 Sodetz JM, Paulson JC, Pizzo SV, McKee PA. Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of especific galactose residues. J Biol Chem 1978; 253: 7202-7208
• 9 De Marco L, Shapiro SS. Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent J Clin Invest 1981; 68: 321-328
• 10 Gralnick HR, Cregger MC, Williams SB. Characterization of the defect of the factor VIII/von Willebrand factor protein in von Willebrand’s disease. Blood 1982; 59: 542-548
• 11 Kao KJ, Pizzo SV, McKee PA. Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets J Biol Chem 1980; 255: 10134-10139
• 12 Vermylen J, Bottecchia D, Szpilman H. Factor VIII and human platelet aggregation. III. Further studies on aggregation of human platelets by neuraminidase-treated human factor VIII. Br J Haematol 1976; 34: 321-330
• 13 Federici AB, Elder JH, De Marco L, Ruggeri ZM, Zimmerman TS. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. J Clin Invest 1984; 74: 2049-2055
• 14 Niiya K, Hodson E, Bader R, Byers-Ward V, Koziol JA, Plow EF, Ruggeri ZM. Increased surface expressions of the membrane glycoprotein IIb/IIIa complex induced platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood 1987; 70 (02) 475-483
• 15 De Marco L, Girolami A, Rusell S, Ruggeri ZM. Interaction of Asialo von Willebrand Factor with Glycoprotein Ib induces Fibrinogen binding to the Glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest 1985; 75: 1198-1203
• 16 Ruggeri ZM, Zimmerman TS. The complex multimeric composition of Factor VIII/von Willebrand factor. Blood 1981; 57: 1140-1143
• 17 Laemmli UK. Cleavage of structural proteins among the assembly of the head of the bacteriophage T4. Nature (London) 1970; 227: 680-682
• 18 Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959; 234: 1971-1975
• 19 Lowry OH, Rosebrough AL, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-267
• 20 Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Micro vase Res 1973; 5: 167-179
• 21 Bastida E, Escolar G, Almirall L, Ordinas A. Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine. Thromb Haemostas 1986; 55: 333-337
• 22 Escolar G, Bastida E, Castillo R, Ordinas A. Development of a computer program to analyze to parameters of platelet-vessel wall interaction. Haemostasis 1986; 16: 8-13
• 23 Baumgartner HR, Muggli R. Adhesion and aggregation: morphological demonstration and quantitation in vivo and in vitro. In: Platelets in Biology and Pathology. Gordon JL. (ed) Elsevier/North-Holland Biomedical Press; Amsterdam: 1976. pp 23-60
• 24 Pareti FI, Fujimura Y, Dent JA, Holland LZ, Zimmerman TS, Ruggeri ZM. Isolation and characterization and localization of a collagen binding domain in human von Willebrand factor. J Biol Chem 1986; 261: 15310-15318
• 25 Roth GJ, Titani K, Hoyer LW, Hickey MJ. Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry 1986; 25: 8357-8362
• 26 Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb/IIIa, Ib, and storage granules. Blood 1986; 67: 322-330
• 27 Sakariassen KS, Nievelstein PM, Coller BS, Sixma JJ. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol 1986; 63: 681-691
• 28 De Marco L, Crovato S, Montgomery RR, Rusell S, Ruggeri ZM. The binding of native and asialo von Willebrand factor to platelets. A study with different stimuli and monoclonal antibodies Blood 1986; a Suppl (Suppl. 62) 254 a
• 29 Lawrence JB, Gralnick R. Asialo von Willebrand factor inhibits platelet adherence to human arterial subendothelium: Discrepancy between Ristocetin cofactor activity and primary hemostatic function. Blood 1987; 70: 1084-1089
• 30 Sakariassen KS, Ottenhof-Roves M, Sixma JJ. Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence. Blood 1984; 63: 996-1003
• 31 De Marco L, Maurcato M, Del Ben MG, Buddle U, Federici AB, Girolami A, Ruggeri ZM. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. The role of platelet activation, fibrinogen and two distinct membrane receptors J Clin Invest 1987; 80: 475-482